Relief Biotech Private Limited - Due diligence report

A 360° intelligence report on Relief Biotech Private Limited: trust score, financial health, credit view, compliance, directors, growth and …

2005-06-01 Roorkee, Uttarakhand Active Unlisted Active Compliant
Share
Connect MCP
RB Relief Biotech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Relief Biotech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
88/100
Trust Score
Low Risk

Relief Biotech Private Limited is assessed as Low Risk with a Trust Score of 88/100. Relief Biotech Private Limited is an active private limited indian non-government company incorporated in 2005, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 09 Aug 2026 from the latest processed filings. Relief Biotech Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
78/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.
  • Externally credit-rated (MSE).

Charges position: 2 open (7.89 cr) · 7 satisfied (20.43 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Indian Overseas Bank5 48.0 cr
Hdfc Bank Limited1 48.0 cr
Ioc2 48.0 cr
Iob1 48.0 cr
Compliance Score: 78/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • Delayed payments to MSME suppliers disclosed (65 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ATUL KUMAR JAIN 01234567 Director 01/04/2018 6 yrs Approved
ANUJ KUMAR JAIN 01234567 Director 01/04/2018 6 yrs Approved
GAURAV JAIN 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a majority stake - exact percentages are part of the full report.

Key managerial personnel: ATUL KUMAR JAIN (Whole-time director) · ANUJ KUMAR JAIN (Whole-time director) · GAURAV JAIN (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 90
Growth signals & trust indicators
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
Operating for 21+ years.
Active GST registration(s).
Distress signals & risk flags
2 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 54.92 Lakh.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence85/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment69/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 7.89 cr already registered.
  • Compliance record supports lending.
Investor view82/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
31 May 2023
Charge created
Indian Overseas Bank - 44.40 Lakh
11 Oct 2022
Charge satisfied
Hdfc Bank Limited
12 Mar 2020
Charge created
Indian Overseas Bank - 7.45 cr
16 Mar 2019
Charge satisfied
Indian Overseas Bank
07 Feb 2019
Charge created
Hdfc Bank Limited - 6.37 cr
08 May 2018
Director ceased
ANCHAL JAIN
31 Jul 2017
Director ceased
VEENA JAIN
21 Nov 2016
Director ceased
SOURABH JAIN
07 Aug 2012
Director ceased
ATUL KUMAR JAIN
Director ceased
ANUJ KUMAR JAIN
Director ceased
GAURAV JAIN
24 Jun 2011
Charge satisfied
Indian Overseas Bank
Charge satisfied
Ioc
10

Key Observations

Auto-generated from the data above
Revenue declined 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of MSE from Crisil.
Promoters hold a majority stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Scoat Pharma Private Limited U24239TG2006PTC049786 Hyderabad, Telangana, India
Moraya Global Limited U24110MH1994PLC076214 Mumbai, Maharashtra, India
Ridley Life Science Private Limited U24232DL2004PTC129295 Delhi, Delhi, India
Marine Medicare Private Limited U24304HP2020PTC007769 Solan, Himachal Pradesh, India
Lexine Technochem Private Limited U24230GJ2010PTC059643 Salvli, Gujarat, India
Ronald Pharmaceutical U24110GJ1993PTC019347 Baroda, Gujarat, India
Brassica Pharma Private Limited U24230MH2006PTC160053 Mumbai, Maharashtra, India
Krushinath Green Energy Limited U15421PN2012PLC142602 Pune, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Relief Biotech Private Limited before audits and certifications: compliance score 78/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Relief Biotech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Relief Biotech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Relief Biotech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Relief Biotech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Relief Biotech Private Limited an active company?

Relief Biotech Private Limited has MCA status “Active” with a compliance score of 78/100 (Low Risk).

Is Relief Biotech Private Limited financially healthy?

Relief Biotech Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Relief Biotech Private Limited?

Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Relief Biotech Private Limited?

Promoters hold a majority stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Relief Biotech Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 7 earlier charge(s) stand satisfied.

Is Relief Biotech Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 78/100 (Low Risk).

Is it risky to lend to Relief Biotech Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.